Health Canada

Is Orforglipron legal in Canada?

Under reviewUnder review at Health Canada since January 2026 (Eli Lilly, new active substance); not yet authorised

A regulator is actively reviewing it.

Health Canada's list of new drug submissions under review, current as of 2026-08-31, includes orforglipron calcium from Eli Lilly Canada, accepted into review in 2026-01 as a new active substance and part of an aligned review with a health technology assessment body. No orforglipron product appears in the Drug Product Database, so it cannot be sold in Canada until Health Canada authorises it.

Last verified 2026-09-29 · how we verify

Molecule

Orforglipron explained →

Country

All rules in Canada →

Orforglipron elsewhere

Sources (2)

01Drug and Health Product Submissions Under Review: New drug submissions under review (list current as of 2026-08-31)Health Canada · 2026-08-31 · accessed 2026-09-29
02Drug Product Database API: active-ingredient search for orforglipronHealth Canada (Drug Product Database) · 2026-09-29 · accessed 2026-09-29